ClinicalTrials.gg
CompletedNCT07949929APHOXsUpdated Nov 19, 2026

Effects of Physical Activity and Hypoxia on Blood Glucose, Blood Pressure and Heart Rate Variability in Healthy Individuals.

An interventional study of Physical activity and Hypoxic exposure in Physical Activity, Exercise and Hypoxia, sponsored by Universite du Littoral Cote d'Opale. Completed at 2 sites in France. Open to male participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-19.

Primary conditionHypoxiaRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Hypoxia
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Hypoxia.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Universite du Littoral Cote d'Opale · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Registered 2 years 7 months after the study started (first participant enrolled Mar 2024, registered Nov 2026).
Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 72 studies in Hypoxia with a site in France — 17 open to participants now, 17 under way, 1 of them phase 3. Hypoxia · France.

Enrollment
47th of 51
13 · median 40
Started
2024
with 5 others
No phase
37 of 72
12 open now
Registered
72nd of 72
by date
Lead sponsor
2 of 72
Universite du Littoral Cote d'Opale

Among the 72 studies in Hypoxia with a site in France, this one is the 47th largest by enrollment of the 51 interventional ones that give a count, is one of 6 that started in 2024, is one of 37 with no phase, and was the 72nd registered.

Hypoxia

1,081 studies on the registry are indexed under Hypoxia; 213 are open to participants now.

Browse Hypoxia studies →

Open to participants now

17 of the 72 studies in Hypoxia with a site in France are open now. Recruiting first, the newest first:

12 more — sign in →

All 17 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 124 Hypoxia studies recruiting now, 52 (42%) set no upper age limit and 46 (37%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.

This study: 18 Years to 65 Years · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 72 studies in Hypoxia with a site in France, or all of them as a file.
02

Study summary

The goal of this clinical trial was to evaluate the effects of sequentially administrated physical activity and hypoxia on blood glucose, blood pressure and heart rate variability, compared to their isolated counterparts, in healthy individuals. The main question was to answer if this organization could be used as a beneficial modulator of metabolic and cardiovascular homeostasis without additional nervous autonomic strain.

Participants were asked to come for 5 visits at the laboratory for the following experimentations:

  1. Inclusion visit with measurements of anthropometric data (height, weight, body composition), cardiorespiratory capacity (cycle ergometer sub-maximal incremental test) and strength of the upper and lower limbs (estimation the maximal repetition with a sub-maximal test).
  2. Physical activity condition: 45 minutes of moderate aerobic exercise on a cycle ergometer (50-60% of the previously estimated maximal aerobic power) followed by 45 minutes of moderate resistance exercise (50-60% of the previously estimated maximal repetition).
  3. Hypoxic condition: resting hypoxic exposure in a close environment with a 14.5% inspired oxygen fraction.
  4. Sequential condition with a halved version of physical exercise (45 minutes) prior to hypoxic exposure (45 minutes).
  5. Unsupervised control condition: measurement of the same outcomes in the daily living conditions.

Visits number 2, 3, 4, 5 were placed in random order.

03

Conditions studied

  • Physical Activity
  • Exercise
  • Hypoxia
  • Blood Glucose Concentration
  • Blood Pressure
  • Heart Rate Variability
  • Healthy Adult

Browse trials for

Keywords

  • Physical Activity
  • Hypoxia
  • Blood glucose
  • Blood pressure
  • Heart rate variability
04

In context

Hypoxia Reclassified

1,081 studies on the registry are indexed under Hypoxia; 213 are open to participants now.

This study's enrollment of 13 is below the median of 45 across 771 interventional studies indexed under Hypoxia.

Browse Hypoxia studies →

Lead sponsor

Universite du Littoral Cote d'Opale is the lead sponsor of 11 studies on the registry; 5 are open to participants now.

Compared within Hypoxia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 to 65 years old
  • Able to perform physical activity

Exclusion criteria

Exclusion Criteria:

  • Living with a metabolic disease (T1DM, T2DM, Obesity)
  • Undergoing pharmacological treatment that could influence blood glucose (metformin, sulfonylureas, )
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

06

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • Other
    Healthy adults

    Healthy participants

    Other: Physical activity · Other: Hypoxic exposure · Other: Sequentially combined physical activity and hypoxia · Other: Unsupervised control

Interventions

  • OtherPhysical activity

    90 minutes of moderate physical activity alone composed of 45 minutes of continuous moderate aerobic exercice (50-60% of estimated maximal aerobic power) and 45 minutes of moderate resistance exercice (50-60% of estimated maximal strenght).

    Also known as: Exercise

  • OtherHypoxic exposure

    Resting in normobaric hypoxia at FiO2 ≈ 14.5%. Hypoxia was provided in a closed environment (tent) with an O2 extractor (Cloud 9, Sporting Edge Ltd, Basingstoke, United Kingdom).

    Also known as: Hypoxia

  • OtherSequentially combined physical activity and hypoxia

    Physical Activity followed by Hypoxia: a reduced-duration condition combining physical activity and hypoxia sequentially, with 20 min of cycling, 20 min of resistance exercise, and 40 min of hypoxic exposure.

    Also known as: Exercise, Hypoxia, Combination

  • OtherUnsupervised control

    A control condition without supervised exercise or hypoxic exposure, during which participants followed their usual daily routine.

    Also known as: Control, Unsupervised, Daily living condition

07

What researchers measure

Primary outcomes

  1. Interstitial glucose concentrations

    Interstitial glucose concentration (mg/dl) measured with continuous glucose monitoring (Freestyle Libre Pro iQ, Abbott, Chicago, Illinois, USA). Coefficient of variation, mean absolute glucose and glucose area under the curve normalised by duration of the observed window were used for analyses.

    Time frame: During the intervention (90min) and up to 24 hours post-intervention.

  2. Ambulatory blood pressure monitoring

    Blood pressure measured with ABPM device every 30 minutes during daytime and every hour during nighttime (ABPM Walk200b, Cardioline S.P.A, Trento, Italy).

    Time frame: Immediately post-intervention through the following morning (range: 14 to 22 hours, depending on session time)

  3. Heart rate variability

    Heart rate variability measured with a thoracic heart rate strap (Polar H10, Polar Electro Oy, Kempele, Finland). RMSSD, pNN50, SDNN and spectral analyses were performed on R-R intervals.

    Time frame: During the 90 min of intervention and the first 6 hours of the following night.

Secondary outcomes

  1. Spontaneous physical activity

    Measurement of the physical activity performed spontaneously by the participants by an accelerometer placed on wrist of the non-dominant arm (GT3X, ActiGraph, Pensacola, Florida, USA). Outcome used for control.

    Time frame: Up to 48 hours (from 1 day pre-intervention to 1 day post-intervention)

  2. Nutritional intake

    Participants used a nutritional diary on the second visit to reproduce the same nutritional intake on the day of each other intervention. Outcome used for standardisation of the study.

    Time frame: Each day of the experiment, from the first to the last session (approximately 4 weeks overall)

08

Study locations

2 sites
  • URePSSS laboratory
    Dunkirk, Nord 59140, France
  • URePSSS laboratory - Eurasport Facility
    Loos, Nord 59120, France
09

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2024 to primary completion in Apr 2026, 25 months.

Of 324 non-industry interventional studies with no phase under Hypoxia, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's 25 months is above that.

Counting every sponsor, half of 354 studies reached it within 12 months; a quarter within 3 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 19, 2026
StartActual
Mar 22, 2024
Primary completionActual
Apr 30, 2026
CompletionActual
May 1, 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07949929
Lead sponsor
Universite du Littoral Cote d'Opale
Collaborators
Santelys Association
Responsible party
Herve DEVANNE, PhD (Professor, Universite du Littoral Cote d'Opale) — Principal investigator
First posted
Nov 19, 2026
Start date
Mar 22, 2024
Primary completion
Apr 30, 2026
Completion
May 1, 2026
Last update
Nov 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion